Who’s Who: Dr. Mohammad Al-Suliman, CEO of Najm for Insurance Services

Dr. Mohammad Al-Suliman
Short Url
Updated 28 July 2021
Follow

Who’s Who: Dr. Mohammad Al-Suliman, CEO of Najm for Insurance Services

Dr. Mohammad Al-Suliman has been the CEO of Najm for Insurance Services since February 2019.

He specializes in transformation and change management for organizations revamping their strategy and business models. Additionally, Al-Suliman is an accredited expert in global project management and mergers and acquisitions.

Al-Suliman restructured Najm’s traditional revenue and pricing model to be sales-driven and correlated to the financial strength of the industry, ensuring alignment to the objectives of Saudi Arabia’s Vision 2030, making its services fully automated and 95 percent online.

He has held leadership positions in various sectors, including in telecoms, banking and investment management.

Prior to joining Najm, he served as vice president of corporate development at Saudi Telecom Co., and before that, he was chief operating officer at the Saudi Kuwaiti Finance House, and vice president of Klever Marketing in the US.

His earlier experience encompassed many executive and leadership positions including vice president of the operations and support services division at Arabian Securities, director of business systems development at Jadwa Investment, and head of investment group systems at the Arab National Bank.

Al-Suliman obtained a doctorate in strategic management and information technology from Claremont Graduate University, California, in 2015.

He did a master’s degree in information systems and technology from Claremont in 2011, having received his bachelor’s degree in Management Information System from King Fahd University of Petroleum and Minerals in Saudi Arabia in 2001.

Al-Suliman was named as the best CEO in the insurance category for 2020 by International Business Magazine.

His hobbies include extreme sports like scuba diving, sky diving, cycling and aviation. He is a certified VFR pilot.


Saudi hospital pioneers preventive type 1 diabetes treatment

KFSH&RC has introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes. (SPA)
Updated 13 sec ago
Follow

Saudi hospital pioneers preventive type 1 diabetes treatment

RIYADH: King Faisal Specialist Hospital and Research Center introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes, the Saudi Press Agency reported on Wednesday.
The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease. It marks the first time such a treatment has been implemented in the Kingdom.
The initial application involved two patients who met all the criteria outlined in the approved protocol. The step represents a major advance in early preventive care for one of the most common autoimmune conditions affecting children and adolescents.
Both cases were treated at the hospital’s Department of Pediatrics. For families already managing type 1 diabetes, the innovation brings new hope.
Siblings of affected children often face increased risk due to shared genetic and immune factors. Preventive options like this could significantly lower those risks in the future.
The treatment targets the early, pre-type 1 diabetes stage when insulin-producing pancreatic cells begin to deteriorate. Through early intervention, doctors can slow this damage, delay the onset of symptoms and help extend the time before full disease progression.
Implementing the therapy required careful preparation. The drug was compounded in the hospital pharmacy under a precise protocol, while nursing teams received training on administration, monitoring and managing possible reactions.
Medical staff were also briefed on patient selection and follow-up criteria based on the latest clinical guidelines.
According to the SPA, experts expect the program to inspire national research focused on the early stages of the disease and on developing preventive approaches that enhance quality of life for at-risk groups.
KFSH&RC continues to gain recognition on the global stage. It was ranked first in the Middle East and Africa, and 15th worldwide among the top 250 academic medical centers for 2025.
The hospital was also named the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance 2025.
Additionally, Newsweek included KFSH&RC on its lists of the World’s Best Hospitals (2025), the World’s Smartest Hospitals (2026) and the World’s Best Specialized Hospitals (2026).